(iii) Tocilizumab and Sarilumab:
These are monoclonal antibodies which can be used to treat rheumatoid arthritis. They can help in preventing cytokine storm which can be happens when there is an overproduction of immune cells which attacking self-antigens instead of defending it (Ahmed, 2020).
The Punjab government has approved the use of Actrema, a lifesaving drug for critical patients. This can be prescribed to patients who develop lung complications and abnormal level of interleukin 6 in the blood. The IL-6 is an endogenous chemical which causes inflammation. These can be useful for some patients only because there is a high risk of increase infection level (Chaudhry, 2020a).